Response Evaluation Criteria In Solid Tumors abbreviated as RECIST, is a standard way to measure how well a cancer patient responds to treatment. The set of rules define when tumors in cancer patients improve (“respond”), stay the same (“stabilize”), or worsen (“progress”) during treatment. Basically, it’s a standard way to measure if tumors shrink, stay the same, or get bigger.

<< Back to Glossary Index